| Mutational profile of metastatic breast cancers: a retrospective analysis C Lefebvre, T Bachelot, T Filleron, M Pedrero, M Campone, JC Soria, ... PLoS medicine 13 (12), e1002201, 2016 | 373 | 2016 |
| Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects C Borg, M Terme, J Taïeb, C Ménard, C Flament, C Robert, K Maruyama, ... The journal of clinical investigation 114 (3), 379-388, 2004 | 360 | 2004 |
| Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer R Condorelli, L Spring, J O’shaughnessy, L Lacroix, C Bailleux, V Scott, ... Annals of Oncology 29 (3), 640-645, 2018 | 297 | 2018 |
| Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy V Quidville, S Alsafadi, A Goubar, F Commo, V Scott, C Pioche-Durieu, ... Cancer research 73 (7), 2247-2258, 2013 | 162 | 2013 |
| A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma C Gaudin, F Kremer, E Angevin, V Scott, F Triebel The Journal of Immunology 162 (3), 1730-1738, 1999 | 134 | 1999 |
| A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating … C Ronsin, V Chung-Scott, I Poullion, N Aknouche, C Gaudin, F Triebel The Journal of Immunology 163 (1), 483-490, 1999 | 133 | 1999 |
| Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab M Cizkova, ME Dujaric, J Lehmann-Che, V Scott, O Tembo, B Asselain, ... British journal of cancer 108 (9), 1807-1809, 2013 | 104 | 2013 |
| In vivo T-cell clonal amplification at time of acute graft-versus-host disease PY Dietrich, A Caignard, A Lim, V Chung, JL Pico, C Pannetier, ... | 94 | 1994 |
| Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis F André, S Michiels, P Dessen, V Scott, V Suciu, C Uzan, V Lazar, ... The lancet oncology 10 (4), 381-390, 2009 | 78 | 2009 |
| Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis M Peyre, F Commo, C Dantas-Barbosa, F Andreiuolo, S Puget, L Lacroix, ... PloS one 5 (9), e12932, 2010 | 67 | 2010 |
| Chk1 as a new therapeutic target in triple-negative breast cancer L Albiges, A Goubar, V Scott, C Vicier, C Lefèbvre, S Alsafadi, F Commo, ... The Breast 23 (3), 250-258, 2014 | 61 | 2014 |
| Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening E Ruiz-Garcia, V Scott, C Machavoine, JM Bidart, L Lacroix, S Delaloge, ... British journal of cancer 102 (3), 462-468, 2010 | 59 | 2010 |
| Ribosomal RNA 2′ O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer V Marcel, J Kielbassa, V Marchand, KS Natchiar, H Paraqindes, ... NAR cancer 2 (4), zcaa036, 2020 | 56 | 2020 |
| Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial M Arnedos, MA Bayar, B Cheaib, V Scott, I Bouakka, A Valent, J Adam, ... Annals of Oncology 29 (8), 1755-1762, 2018 | 54 | 2018 |
| Whole exome sequencing of rare aggressive breast cancer histologies MV Dieci, V Smutná, V Scott, G Yin, R Xu, P Vielh, MC Mathieu, C Vicier, ... Breast cancer research and treatment 156, 21-32, 2016 | 50 | 2016 |
| BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy AS Hamy, I Bieche, J Lehmann-Che, V Scott, P Bertheau, ... Breast cancer research and treatment 159, 499-511, 2016 | 47 | 2016 |
| Circannual rhythm in natural killer activity and mitogen responsiveness of murine splenocytes AK Pati, I Florentin, V Chung, M De Sousa, F Levi, G Mathe Cellular immunology 108 (1), 227-234, 1987 | 47 | 1987 |
| Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy MC Mathieu, C Mazouni, NC Kesty, Y Zhang, V Scott, J Passeron, ... Annals of oncology 23 (8), 2046-2052, 2012 | 44 | 2012 |
| T-cell receptor repertoire in neuroblastoma patients D Valteau, V Scott, G Carcelain, O Hartmann, B Escudier, T Hercend, ... Cancer research 56 (2), 362-369, 1996 | 38 | 1996 |
| Contagious apoptosis facilitated by the HIV-1 envelope: fusion-induced cell-to-cell transmission of a lethal signal K Andreau, JL Perfettini, M Castedo, D Métivier, V Scott, G Pierron, ... Journal of cell science 117 (23), 5643-5653, 2004 | 37 | 2004 |
Stefan MichielsOffice Biostatistics & Epidemiology, Gustave Roussy; Oncostat, Univ. Paris Saclay, INSERM在 gustaveroussy.fr 的电子邮件经过验证
